Physician profile
Jill Whelan
NPI 1477848497
$2,309.90
in general payments reported to CMS, 2019-2025
18 companies · $637 in 2025
The $637 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.73 · 2020: $28.49 · 2021: $125 · 2022: $396 · 2023: $385 · 2024: $724 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,746.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $472.72 | 2021-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $295.91 | 2019-2025 | |
| Pfizer INC. | $258.59 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $168.95 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.26 | 2020-2025 | Jardiance |
| Amgen INC. | $138.09 | 2022-2024 | Repatha |
| Heartflow, INC. | $131.47 | 2022-2025 | Ffrct |
| Alnylam Pharmaceuticals INC. | $122.28 | 2021-2025 | Onpattro |
| Novo Nordisk INC | $117.10 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Irhythm Technologies, INC. | $86.07 | 2024 | Zio Xt Patch, Zio Monitor |
| Scpharmaceuticals INC. | $74.33 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $67.98 | 2022-2023 | Verquvo |
| Boston Scientific Corporation | $62.46 | 2025 | Watchman Flx |
| Abbott Laboratories | $44.98 | 2025 | Cardiomems, Amplatzer Amulet |
| Astrazeneca Pharmaceuticals Lp | $36.94 | 2022-2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $26.50 | 2025 | Juxtapid |
| Kiniksa Pharmaceuticals International, Plc | $25.80 | 2024 | Arcalyst |
| Medtronic, INC. | $22.47 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Whelan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.